Home
Scholarly Works
Guidance adherent dabigatran etexilate treatment...
Conference

Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate

Authors

Lip G; Clemens A; Noack H; Ferreira J; Connolly S; Yusuf S

Volume

34

Pagination

pp. 791-791

Publisher

OXFORD UNIV PRESS

Publication Date

August 1, 2013

Name of conference

Congress of the European-Society-of-Cardiology (ESC)

Conference place

Amsterdam, NETHERLANDS

Conference start date

August 31, 2013

Conference end date

September 4, 2013

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X

Contact the Experts team